Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Unpredictability remains the one constant with seasonal influenza
• ACIP confirms recommendation for annual influenza vaccination
• CDC, AAP approve recommended pediatric immunization schedules for 2015
• Ninety percent of HIV transmissions linked to people not in care
• Senate health committee discusses measles, vaccination strategies
• UCLA reports CRE exposure related to endoscopic procedure
• The Ebola epidemic: No effective therapy without proper diagnosis Emmanuel d'Harcourt, MD, MPH
• Ebola virus disease: Lessons learned Donald Kaye, MD, MACP
• FDA approves Avycaz for cIAIs, cUTIs in adults
• Xpert MTB/RIF assay cleared to determine if TB patients need isolation
• ACIP's 2015 adult immunization schedule includes update for PCV13
• Aggressive HIV strain identified in Cuba
• Artemisinin resistance threatens to spread to India
• Biomarker levels associated with IRIS in patients with HIV, TB
• Clearance of MRSA colonization occurs earlier than previously described
• Convalescent blood transfusion may reduce Ebola-related mortality
• Cough, fever may be reliable prediction model for influenza
• Cough, fever may be reliable prediction model for influenza
• Craigslist personals linked to increase in reported HIV cases
• Desloratadine may kill Lyme disease-causing bacteria
• Ethical challenges loom over digital epidemiology, data collection
• Half of US teenage girls fail to receive HPV vaccine at recommended age
• HAV hospitalizations increase significantly since 1999
• Health insurance price-tiering of HIV drugs may deter high-cost patients
• Land use changes may spark re-emergence of plague
• Majority of hospitals have antimicrobial stewardship policies
• Medicaid reimbursements under ACA improved appointment availability
• More surveillance techniques increase rate of superficial SSIs
• Multifaceted intervention improved influenza vaccination in pediatric cancer cases
• No unexpected safety concerns observed after adult MMR vaccination
• Obesity related to influenza-associated respiratory mortality
• Online comments impact opinions on vaccination
• Physicians frequently prescribe unnecessary antibiotics for RTIs
• PTLDS costs estimated at $1 billion annually in US
• Role of hospital epidemiologist growing, more resources needed
• Smartphone accessory tests for HIV, syphilis
• Steroids decrease treatment failure in severe pneumonia
• Tamiflu shows no effect on duration of viral shedding
• TMP-SMX/spironolactone combination increased sudden death in seniors
• VOICE trial shows low PrEP adherence, efficacy among women
• ALLY-2: Daclatasvir/Sovaldi render high SVR rates in HIV/HCV patients
• Attendance to HIV services at Guinea clinic declines sharply during Ebola epidemic
• Clustered transmission responsible for majority of XDR-TB cases
• CVD mortality rates greater among those with HIV
• High-dose rifampin reduced time to TB culture conversion
• JIKI trial: Favipiravir shows some benefit in Ebola treatment
• 'On-demand' PrEP regimen successful among MSM
• PrEP demonstrates more protection than expected in real-life setting
• PrEP use high, effective among HIV serodiscordant African couples
• PROMISE: Triple antiretroviral regimens effectively prevent mother-to-child HIV transmission
• Ryan White patients with HIV more likely to undergo ART
• Statins reduced non-calcified coronary plaque in HIV patients
• Status disclosure patterns related to HIV care retention, viral load
• Tenofovir gel fails to prevent HIV infection in women
• Text message reminders did not improve ART adherence
• The burden of pneumococcal disease and challenges with adult vaccination Jeff Brock, PharmD, MBA, BCIDP